FDA Approved: SULINDAC — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for sulindac from Actavis Pharma, Inc. This action updates the labeling for the drug under the approved supplement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Sulindac (sulindac)

Snippet

SUPPL AP for SULINDAC (SULINDAC)